Literature DB >> 8637202

Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases.

N Naka1, M Ohsawa, Y Tomita, H Kanno, A Uchida, A Myoui, K Aozasa.   

Abstract

Data for prognostic factors in angiosarcoma (AS) are limited, prompting a large-scale study of AS with multivariate analysis. To analyze prognostic factors in angiosarcoma (AS), clinical and histologic findings in 55 patients collected from hospitals in Japan were reviewed. Prognostic factors were evaluated by univariate and multivariate Cox's proportional hazards models. The study involved 32 males and 23 females, ages 18-93 (median, 69) years. The primary sites of tumors included head and neck (32 cases), trunk (10), extremities (3), spleen (3), breast (3), and other (4). The overall 2-year survival rate was 21%. Univariate analysis of clinical factors including age, sex, size and depth of tumor, tumor-related symptoms, interval between onset of symptoms and admission, surgical procedures, adjuvant chemotherapy, and adjuvant radiotherapy showed that age, tumor size, and mode of treatment were significant for survival. Histologic factors analyzed were mitotic counts, cellularity, cellular pleomorphism, extent of necrosis, vascular differentiation, and nonspecific diagnosis. Only mitotic counts were significant for prognosis. Multivariate analysis on these four factors revealed that tumor size, mode of treatment, and mitotic counts were independent prognostic factors.

Entities:  

Mesh:

Year:  1996        PMID: 8637202     DOI: 10.1002/(SICI)1096-9098(199603)61:3<170::AID-JSO2>3.0.CO;2-8

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  49 in total

1.  Cutaneous angiosarcoma of the eyelids.

Authors:  R M Conway; T Hammer; A Viestenz; L M Holbach; R M Conway
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

Review 2.  Angiosarcomas and taxanes.

Authors:  Nicolas Penel; Amélie Lansiaux; Antoine Adenis
Journal:  Curr Treat Options Oncol       Date:  2007-12-08

3.  Outcomes of Systemic Therapy for Patients with Metastatic Angiosarcoma.

Authors:  Sandra P D'Angelo; Rodrigo R Munhoz; Deborah Kuk; Johnathan Landa; Eliza W Hartley; Michael Bonafede; Mark A Dickson; Mrinal Gounder; Mary L Keohan; Aimee M Crago; Cristina R Antonescu; William D Tap
Journal:  Oncology       Date:  2015-06-03       Impact factor: 2.935

4.  Stewart Treves Syndrome: A Case Report.

Authors:  Ali Güleç; Harun Kütahya; Nazım Karalezli; Burkay Kacira; M Ali Acar
Journal:  Oman Med J       Date:  2014-03

5.  The importance of surgery in scalp angiosarcomas.

Authors:  Richard J Cassidy; Jeffrey M Switchenko; Melinda L Yushak; Nicholas Madden; Mohammad K Khan; David K Monson; Jonathan J Beitler; Jerome C Landry; Karen D Godette; Theresa W Gillespie; Kirtesh R Patel
Journal:  Surg Oncol       Date:  2018-09-13       Impact factor: 3.279

Review 6.  Angiosarcoma of the ovary in an 11 year old girl: case report and review of the literature.

Authors:  Ermina Iljazović; Snježana Tomić; Jasminka Mustedanagić-Mujanović; Zinaida Karasalihović; Majda Kuljanin; Zlatan Fatušić; Elvira Konjić; Edin Husarić; Amila Latifagić; Lejla Arnautalić
Journal:  Bosn J Basic Med Sci       Date:  2011-05       Impact factor: 3.363

7.  Colonic angiosarcoma: A case report and review of literature.

Authors:  Osama S Al Beteddini; Daniel Brenez; Christophe Firket; Roberto Algaba; Ahmad Tabech
Journal:  Int J Surg Case Rep       Date:  2012-12-03

8.  MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema.

Authors:  Johanna Manner; Bernhard Radlwimmer; Peter Hohenberger; Katharina Mössinger; Stefan Küffer; Christian Sauer; Djeda Belharazem; Andreas Zettl; Jean-Michel Coindre; Christian Hallermann; Jörg Thomas Hartmann; Detlef Katenkamp; Kathrin Katenkamp; Patrick Schöffski; Raf Sciot; Agnieszka Wozniak; Peter Lichter; Alexander Marx; Philipp Ströbel
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

9.  Stewart-Treves syndrome: Case report and literature review.

Authors:  Radovan Vojtíšek; Emília Sukovská; Marika Kylarová; Denisa Kacerovská; Jan Baxa; Barbora Divišová; Jindřich Fínek
Journal:  Rep Pract Oncol Radiother       Date:  2020-10-01

10.  Pazopanib treatment slows progression and stabilizes disease in patients with taxane-resistant cutaneous angiosarcoma.

Authors:  Dai Ogata; Hiroto Yanagisawa; Kenji Suzuki; Kohei Oashi; Naoya Yamazaki; Tetsuya Tsuchida
Journal:  Med Oncol       Date:  2016-09-09       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.